Novavax’s COVID-19 vaccine could be postponed

Four days before an FDA panel endorsed the Novavax vaccine 21-0, the biotech company informed the FDA of changes to its manufacturing process, according to CNBC. 

Read the full post at Becker's Hospital Review - Healthcare News